FindTrial
Sign In

Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19)

Clinical characteristics of severe or critically ill patients infected with 2019-nCoV

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030803
Enrollment
Unknown
Registered
2020-03-15
Start date
2020-01-31
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

severe patients:none

Sponsors

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patients who had been confirmed with SARS-CoV-2 infection by a nucleic acid-positive test and identified as severe or critical according to the diagnosis and treatment protocol for novel coronavirus pneumonia , were enrolled in this study

Exclusion criteria

Exclusion criteria: Patients who are younger than 18 years , who have severe liver or kidney dysfunction,or patients with other condition evaluated by doctors were excluded from this study.

Design outcomes

Primary

MeasureTime frame
age;sex;comorbidities;chest-CT examination;standard blood counts;albumin;pre-albumin;hemoglobin;alanine transaminase;aspartate transaminase;creatinine;glucose;lipids;procalcitonin;C-reactive protein;coagulation function;nutritional risk screening;body weight;body height;prognosis;—

Contacts

Public ContactXin Li

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

314440820@qq.com+86 13797062903

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026